1. Home
  2. Analysis
  3. Ammonium-lactate
  4. Emtriva

Ammonium lactate and Emtriva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ammonium lactate (ammonium lactate) and Emtriva (emtricitabine). Common drug interactions include hyperkalaemia among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Ammonium lactate and Emtriva. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Ammonium lactate?

Ammonium lactate has active ingredients of ammonium lactate. eHealthMe is studying from 2,151 Ammonium lactate users. Check the latest studies of Ammonium lactate.

What is Emtriva?

Emtriva has active ingredients of emtricitabine. eHealthMe is studying from 2,383 Emtriva users. Check the latest studies of Emtriva.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

11 people who take Ammonium lactate and Emtriva together, and have interactions are studied.

Ammonium lactate and Emtriva drug interactions.

What are the common drug interactions of Ammonium Lactate and Emtriva, by gender? *:

female:

  1. Hyperkalaemia (damage to or disease of the kidney)
  2. Renal failure (kidney dysfunction)
  3. Anxiety
  4. Anaemia (lack of blood)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Chronic kidney disease
  7. Depression
  8. Emotional distress
  9. Hypertension (high blood pressure)
  10. Nephrogenic anaemia (anaemia due to kidney disease)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Decreased activity
  4. Fatigue (feeling of tiredness)
  5. Foot fracture
  6. Hepatitis c
  7. Hyperkalaemia (damage to or disease of the kidney)
  8. Nephropathy (damage to or disease of a kidney)
  9. Quality of life decreased
  10. Renal tubular necrosis (death of kidney tubules)

What are the common drug interactions of Ammonium Lactate and Emtriva, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chronic kidney disease
  2. Hyperkalaemia (damage to or disease of the kidney)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Nephropathy (damage to or disease of a kidney)
  5. Renal failure (kidney dysfunction)

30-39:

  1. Anxiety
  2. Anaemia (lack of blood)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Depression
  5. Emotional distress
  6. Hyperkalaemia (damage to or disease of the kidney)
  7. Hypertension (high blood pressure)
  8. Pain
  9. Pneumonia
  10. Renal failure (kidney dysfunction)

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Decreased activity
  5. Emotional distress
  6. Fatigue (feeling of tiredness)
  7. Nephropathy (damage to or disease of a kidney)
  8. Pain
  9. Quality of life decreased
  10. Renal failure (kidney dysfunction)

50-59:

  1. Emotional distress
  2. Foot fracture
  3. Osteoporosis (bones weak and more likely to break)
  4. Pain
  5. Renal failure (kidney dysfunction)
  6. Renal tubular necrosis (death of kidney tubules)
  7. Antisocial behaviour
  8. Depression
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Anxiety

60+:

  1. Anaemia (lack of blood)
  2. Chronic kidney disease
  3. Hepatitis c
  4. Hyperkalaemia (damage to or disease of the kidney)
  5. Hypertension (high blood pressure)
  6. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Hiv Infection: 11 people, 100.00%
  2. Skin Disorder (skin disease): 2 people, 18.18%
  3. Asthma: 2 people, 18.18%
  4. Bacterial Infection: 2 people, 18.18%
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 18.18%
  6. Cardiac Disorder: 2 people, 18.18%
  7. Cough: 2 people, 18.18%
  8. Fungal Infection: 2 people, 18.18%
  9. Gastric Disorder (disease of stomach): 2 people, 18.18%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Ammonium lactate and Emtriva?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ammonium lactate and Emtriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ammonium lactate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Emtriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ammonium lactate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Emtriva and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ammonium lactate and emtricitabine (the active ingredients of Ammonium lactate and Emtriva, respectively), and Ammonium lactate and Emtriva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.